Publication:
Synthesis, anticancer activity, toxicity evaluation and molecular docking studies of novel phenylaminopyrimidine-(thio)urea hybrids as potential kinase inhibitors

Simple item page
dc.contributor.authorTÜRE, ASLI
dc.contributor.authorsTure, Asli; Kahraman, Deniz Cansen; Cetin-Atalay, Rengul; Helvacioglu, Sinem; Charehsaz, Mohammad; Kucukguzel, Ilkay
dc.date.accessioned2022-03-12T22:38:31Z
dc.date.available2022-03-12T22:38:31Z
dc.date.issued2019
dc.description.abstractThirty-two novel urea/thiourea compounds as potential kinase inhibitor were designed, synthesized and evaluated for their cytotoxic activity on breast (MCF7), colon (HCT116) and liver (Huh7) cancer cell lines. Compounds 10, 19 and 30 possessing anticancer activity with IC50 values of 0.9, 0.8 and 1.6 mu M respectively on Huh7 cells were selected for further studies. These hit compounds were tested against liver carcinoma panel. Real time cell electronic sensing assay was used to evaluate the effects of the compounds 10, 19 and 30 on the growth pattern of liver cancer cells. Apoptotic cell death and cell cycle analysis upon treatment of liver carcinoma cells with hit compounds were determined. A significant apoptotic cell death was detected upon treatment of Huh7 and Mahlavu cells with compound 30 after 48 h of treatment. Additionally, compound 10 caused cell cycle arrest at G0/G1 phase. Mutagenicity of hit compounds was evaluated. Assertively, these compounds were not found to be mutagenic on Salmonella typhimurium strains TA98 and TA100. To understand the binding modes of the synthesized compounds, molecular docking studies were performed using the crystal data of VEGFR and Src-kinase enzymes in correlation with anticancer activities.
dc.identifier.doi10.1016/j.compbiolchem.2018.12.003
dc.identifier.eissn1476-928X
dc.identifier.issn1476-9271
dc.identifier.pubmed30579980
dc.identifier.urihttps://hdl.handle.net/11424/235655
dc.identifier.wosWOS:000459524900024
dc.language.isoeng
dc.publisherELSEVIER SCI LTD
dc.relation.ispartofCOMPUTATIONAL BIOLOGY AND CHEMISTRY
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectPhenylaminopyrimidines
dc.subjectUreas
dc.subjectThioureas
dc.subjectCancer
dc.subjectMolecular docking
dc.subjectSrc-kinase
dc.subjectVEGFR
dc.subjectBIOLOGICAL EVALUATION
dc.subjectTHIOUREA DERIVATIVES
dc.subjectUREA DERIVATIVES
dc.subjectDESIGN
dc.subjectIMATINIB
dc.titleSynthesis, anticancer activity, toxicity evaluation and molecular docking studies of novel phenylaminopyrimidine-(thio)urea hybrids as potential kinase inhibitors
dc.typearticle
dspace.entity.typePublication
local.avesis.id7daf9d0e-600e-4760-afb3-7a107507faed
local.import.packageSS17
local.indexed.atWOS
local.indexed.atSCOPUS
local.indexed.atPUBMED
local.journal.numberofpages15
local.journal.quartileQ3
oaire.citation.endPage241
oaire.citation.startPage227
oaire.citation.titleCOMPUTATIONAL BIOLOGY AND CHEMISTRY
oaire.citation.volume78
relation.isAuthorOfPublication515da16e-3e07-453b-bfbb-c60fbd768648
relation.isAuthorOfPublication.latestForDiscovery515da16e-3e07-453b-bfbb-c60fbd768648

Files

Collections

Research Outputs